Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Basic and translational research

Extended report

Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway

Authors

I González-Alvaro PubMed articles Google scholar articles
A M Ortiz PubMed articles Google scholar articles
C Domínguez-Jiménez PubMed articles Google scholar articles
A Aragón-Bodi PubMed articles Google scholar articles
B Díaz Sánchez PubMed articles Google scholar articles
F Sánchez-Madrid PubMed articles Google scholar articles

Correspondence to Dr I Gonzalez-Alvaro, Rheumatology Unit, Hospital Universitario de la Princesa. Madrid, Spain; isidoro.ga{at}ser.es

Citation

González-Alvaro I, Ortiz AM, Domínguez-Jiménez C, et al

Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway

Annals of the Rheumatic Diseases 2009;68:1644-1650.

Publication history

Accepted October 3, 2008
First published October 28, 2008.

Online issue publication

October 25, 2017

Copyright information

BMJ Publishing Group Ltd and European League Against Rheumatism. All rights reserved.